Synthesis of Multifunctional Fe3O4–CdSe/ZnS Nanoclusters Coated with Lipid A toward Dendritic Cell-Based Immunotherapy
Source abstract
Abstract
We demonstrate a novel route to synthesize Fe3O4-CdSe/ZnS multifunctional nanoclusters (MNCs) with excellent optical and magnetic properties and biocompatibility. The successful fabrication of highly fluorescent and magnetic MNCs is achieved via a coupling process based on a partial ligand exchange reaction at the aqueous-organic solution interface. In addition, we show that dendritic cells (DCs), the sentinel of the immune system, can uptake the MNCs without significant change in cell viability. The MNCs uptaken by the DCs can be used for imaging, tracking, and separating the DCs. Furthermore, the MNCs can be loaded with a pathogen-associated molecular pattern, lipid A, via a hydrophobic-hydrophobic interaction. Ex vivo labeling of DCs with the MNC-lipid A complex enhances the DC migration to draining lymph nodes and tumor antigen-specific T cell responses in vivo. Our work may contribute to the development of synthetic routes to various multifunctional nanoclusters and DC-based cancer immunotherapies.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Immunotherapy and Immune Responses · Nanoparticle-Based Drug Delivery · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Materials Science and Engineering, Korea University, Seoul 136-713, Republic of Korea
Department of Microbiology and Immunology, Seoul National University College of Medicine, and Institute of Endemic Disease, Seoul National University Medical Research Center and Bundang Hospital, Seoul 110-799, Republic of Korea
References (51)
Show source-provided references
1. Kim J. · Adv. Mater. · 2008 · 20 · 47810.1002/adma.200701726 ↗
2. Lee J. E. · Acc. Chem. Res. · 2011 · 44 · 89310.1021/ar2000259 ↗
3. Wang G. N. · Analyst · 2011 · 136 · 178310.1039/c1an15036g ↗
4. Lee D. E. · Chem. Soc. Rev. · 2012 · 41 · 265610.1039/C2CS15261D ↗
5. Vanneman M. · Nat. Rev. Cancer · 2012 · 12 · 23710.1038/nrc3237 ↗
6. Sabado R. L. · Immunotherapy · 2010 · 2 · 3710.2217/imt.09.43 ↗
7. Palucka A. K. · Immunol. Rev. · 2007 · 220 · 12910.1111/j.1600-065X.2007.00575.x ↗
8. Melief C. J. · Immunity · 2008 · 29 · 37210.1016/j.immuni.2008.08.004 ↗
9. Cho N. H. · Nat. Nanotechnol. · 2011 · 6 · 67510.1038/nnano.2011.149 ↗
10. Palucka K. · Nat. Rev. Cancer · 2012 · 12 · 26510.1038/nrc3258 ↗
11. Gilboa E. · J. Clin. Invest. · 2007 · 117 · 119510.1172/JCI31205 ↗
12. Lindquist R. L. · Nat. Immunol. · 2004 · 5 · 124310.1038/ni1139 ↗
13. Prince H. M. · J. Immunother. · 2008 · 31 · 16610.1097/CJI.0b013e31815c5153 ↗
14. Baumjohann D. · Eur. J. Immunol. · 2006 · 36 · 254410.1002/eji.200535742 ↗
15. de Vries I. J. · Nat. Biotechnol. · 2005 · 23 · 140710.1038/nbt1154 ↗
16. Dekaban G. A. · J. Immunother. · 2009 · 32 · 24010.1097/CJI.0b013e318197b2a0 ↗
17. Frick S. U. · Macromol. Biosci. · 2012 · 12 · 163710.1002/mabi.201200223 ↗
18. Cheng Z. L. · Science · 2012 · 338 · 90310.1126/science.1226338 ↗
19. Lu Z. D. · Nano Lett. · 2011 · 11 · 340410.1021/nl201820r ↗
20. Trinh T. T. · RSC Adv. · 2011 · 1 · 10010.1039/c1ra00012h ↗
21. Gao J. H. · J. Am. Chem. Soc. · 2008 · 130 · 371010.1021/ja7103125 ↗
22. Ge J. P. · Angew. Chem., Int. Ed. · 2007 · 46 · 434210.1002/anie.200700197 ↗
23. Cheng C. M. · J. Mater. Chem. · 2009 · 19 · 878210.1039/b910832g ↗
24. Bae W. K. · Adv. Mater. · 2009 · 21 · 169010.1002/adma.200801908 ↗
25. Zhang W. J. · ACS Nano · 2012 · 6 · 1106610.1021/nn304765k ↗
26. Smith A. M. · Ann. Biomed. Eng. · 2006 · 34 · 310.1007/s10439-005-9000-9 ↗
27. Ye M. M. · Chem.—Eur. J. · 2010 · 16 · 624310.1002/chem.200903516 ↗
28. Baumgartner J. · PLoS One · 2013 · 8 · e5707010.1371/journal.pone.0057070 ↗
29. Cullity B. D. · 2001
30. Hermanson G. T. · 1996
31. Pong B. K. · Langmuir · 2008 · 24 · 527010.1021/la703431j ↗
32. Giovanelli E. · Langmuir · 2012 · 28 · 1517710.1021/la302896x ↗
33. Bao Y. P. · J. Phys. Chem. C · 2007 · 111 · 194110.1021/jp066871y ↗
34. Wang C. · J. Am. Chem. Soc. · 2010 · 132 · 652410.1021/ja101305x ↗
35. Xuan S. H. · Chem. Mater. · 2009 · 21 · 507910.1021/cm901618m ↗
36. Ge J. P. · Chem.—Eur. J. · 2007 · 13 · 715310.1002/chem.200700375 ↗
37. Hoppens M. A. · J. Colloid Interface Sci. · 2014 · 413 · 16710.1016/j.jcis.2013.09.016 ↗
38. Zhang L. · Appl. Surf. Sci. · 2006 · 253 · 261110.1016/j.apsusc.2006.05.023 ↗
39. Lan Q. · J. Colloid Interface Sci. · 2007 · 310 · 26010.1016/j.jcis.2007.01.081 ↗
40. 10.1002/9780470027318.a560610.1002/9780470027318.a5606 ↗
41. Sun C. · Adv. Drug Delivery Rev. · 2008 · 60 · 125210.1016/j.addr.2008.03.018 ↗
42. Moon J. J. · Adv. Mater. · 2012 · 24 · 372410.1002/adma.201200446 ↗
43. Bershteyn A. · J. Controlled Release · 2012 · 157 · 35410.1016/j.jconrel.2011.07.029 ↗
44. Zhang Z. · Biomaterials · 2011 · 32 · 366610.1016/j.biomaterials.2011.01.067 ↗
45. Deng H. · Angew. Chem., Int. Ed. · 2005 · 44 · 278210.1002/anie.200462551 ↗
46. Wu J. M. · ACS Appl. Mater. Interfaces · 2012 · 4 · 304110.1021/am3004076 ↗
47. Park B. S. · Nature · 2009 · 458 · 119110.1038/nature07830 ↗
48. Kagan J. C. · Nat. Immunol. · 2008 · 9 · 36110.1038/ni1569 ↗
49. Husebye H. · EMBO J. · 2006 · 25 · 68310.1038/sj.emboj.7600991 ↗
50. Schmitz J. · Cancer Res. · 2002 · 62 · 5058
51. Bos R. · Cancer Res. · 2005 · 65 · 644310.1158/0008-5472.CAN-05-0666 ↗